The Indian Institute of Technology, Kanpur (IIT-K) has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India, a global pharmaceutical company. This collaboration has been carried on the Startup Incubation and Innovation Centre (SIIC), the technology business incubator of IIT-K. As a part of this new collaboration, Boehringer Ingelheim will provide support to Lenek Technologies, one of the startups incubated at SIIC, IIT Kanpur. This start-up company of IIT-K has developed a handheld X-ray device, through which Lenek Technologies aims to eradicate Tuberculosis (TB) by improving the screening process. Experts are hoping that this will bring about a significant change in TB screening in areas where resources are limited. The collaboration will focus on socially beneficial innovations that can drive transformational change in the healthcare industry. "We are pleased to partner with Boehringer Ingelheim India, a global leader in pharma innovation, in our mission to support socially impactful innovations. This Memorandum of Understanding is a testament to the power of collaboration between academia and industry in driving innovation and creating positive social impact. With this partnership, we aim to leverage our collective expertise and resources to nurture and promote innovative ideas that can bring about significant societal changes," said Professor Abhay Karandikar, Director of IIT Kanpur.
